Apriem Advisors’s Prothena Corp PRTA Stock Holding History

Apriem Advisors’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-9	Closed	–	–	526
2013 Q3	$0	Hold	9	–	–	﹤0.01%	512
2013 Q2	$0	Buy	+9	New	+$84	﹤0.01%	476

Other funds holding PRTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Apriem Advisors's PRTA Position: Q4 2013 in Review

Apriem Advisors sold out of Prothena Corp (PRTA) in Q4 2013, closing a stake of 9 shares.

Apriem Advisors first reported a position in PRTA in Q2 2013 and held it in 2 quarters. The position peaked at $0 in Q3 2013. 107 funds tracked by Wall St. Rank hold PRTA as of Q4 2013.

Apriem Advisors reported no remaining Prothena Corp position as of Q4 2013 after selling out during the quarter.
Apriem Advisors sold 9 Prothena Corp shares in Q4 2013.
Apriem Advisors first reported a position in Prothena Corp in Q2 2013 and held it in 2 quarters.
Apriem Advisors's Prothena Corp position peaked at $0 in Q3 2013.
107 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2013.

Based on Apriem Advisors's 13F filing for Q4 2013, filed 14 Feb 2014.